Right Sylvian Fissure Subarachnoid Hemorrhage Has Electrocardiographic Consequences
Stroke 32:2278-2281, Hirashima,Y.,et al, 2001
Should Stroke Subtype Influence Anticoagulation Decisions to Prevent Recurrence in Stroke Patients with Atrial Fibrillation?
Stroke 32:2828-2832, Evans,A.,et al, 2001
Late Cardiopulmonary Complication of Ventriculo-atrial Shunt
Lancet 358:1608,1569, Milton,C.A.,et al, 2001
Sensory Guillain-Barre Syndrome
Neurol 56:82-86, Oh,S.J.,et al, 2001
Primary Prevention of Ischemic Stroke
Stroke 32:280-299, Goldstein,L.B.,et al, 2001
Systematic Review of Long Term Anticoagulation or Antiplatelet Treatment in Patients with Non-rheumatic Atrial Fibrillation
BMJ 322:321-326, Taylor,F.C.,et al, 2001
Atrial Fibrillation and Stroke
Stroke 32:803-808, Hart,R.G. &Halperin,J.L., 2001
Warfarin Therapy for an Octogenarian who has Atrial Fibrillation
Ann Int Med 134:465-474, Gage,B.F.,et al, 2001
Atrial Fibrillation
NEJM 344:1067-1078, Falk,R.H., 2001
An Epidemic of Arsenic Neuropathy From a Spiked Curry
Neurol 56:1417-1418, Kishi,Y.,et al, 2001
Early Electrodiagnostic Findings in Guillain-Barre Syndrome
Arch Neurol 58:913-917, Gordon,P.H. & Wilbourn,A.J., 2001
Diagnostic Investigation of Patients with Chronic Polyneuropathy: Evaluation of a Clinical Guideline
JNNP 71:205-209,147, Rosenberg, N.R.,et al, 2001
Critical Illness Myopathy
Muscle Nerve 23:1785-1788, Lacomis,D.,et al, 2000
Prevention of Ischaemic Stroke
BMJ 321:1455-1459, Gubitz,G. & Sandercock,P., 2000
Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000
Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000
Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000
Ulnar Neuropathy at the Elbow
Muscle & Nerve 23:450-452, Campbell,W.W., 2000
Anticoagulation for Chronic Atrial Fibrillation
JAMA 283:2901-2903, Stern,S.,et al, 2000
Treating Hyperhidrosis
BMJ 320:1221-1222, Collin,J.&Whatling,P., 2000
Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000
Atrial Fibrilation and the Risk of Cerebral White Matter Lesions
Neurol 54:1795-1801, de Leeuw,F.E.,et al, 2000
Pharmacologic Paralysis and Withdrawal of Mechanical Ventilation at the End of Life
NEJM 342:508-511, Truog,R.D.,et al, 2000
Coexisting Causes of Ischemic Stroke
Arch Neurol 57:1139-1144,1113, Moncayo,J. et al, 2000
Cardiac Involvement in Patients with Acute Neurologic Disease
Arch Int Med 160:3153-3158, Dixit,S.,et al, 2000
Decision Analysis and Guidelines for Anticoagulant Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Lancet 355:956-962, Thomson,R.,et al, 2000
Oral Anticoagulation in Patients with Atrial Fibrillation:Adherence with Guidelines in an Elderly Cohort
Am J Med 106:165-171, White,R.H.,et al, 1999
Prevention of a First Stroke,A Review of Guidelines and a Multidisciplinary Consensus Statement from the National Stroke Association
JAMA 281:1112-1120,1146, Gorelick,P.B.,et al, 1999
Choosing Antithrombotic Therapy for Elderly Patients with Atrial Fibrillation Who are at Risk for Falls
Arch Int Med 159:677-685, Man-Son-Hing,M.,et al, 1999
Preventing Stroke in Patients with Atrial Fibrillation
JAMA 281:1830-1835, Ezekowitz,M.D.&Levine,J.A., 1999
Cervical Root Stimulation in a Case of Classic Neurogenic Thoracic Outlet Syndrome
Muscle & Nerve 22:1287-1292, Felice,K.J.,et al, 1999
Clinicopath Conf,Guillain-Barre Syndrome, Campylobacter Jejuni Enteritis,Case 39-1999
NEJM 341:1996-2003, , 1999
Physician Assistants in Neurology Practice
Neurol 52:1513, Taft,J.M.&Hooker,R.S., 1999
Myocardial Injury and Left Ventricular Performance After Subarachnoid Hemorrhage
Stroke 30:780-786, Mayer,S.A.,et al, 1999
Muscle Pain after Exercise
Lancet 353:1062, Nielen,C.&Mazzone,P., 1999
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Neuroendocrine Lung Tumors and Disorders of the Neuromuscular Junction
Neurol 52:1490-1491, Burns,T.M.,et al, 1999
Chronic Cryptogenic Sensory Polyneuropathy,Clinical and Laboratory Characteristics
Arch Neurol 56:540-547, 519, Wolfe,G.I.,et al, 1999
Factors Associated with Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation, Analysis of 2012 Participants in the SPAF-I-III Clinical Trials
Stroke 30:1223-1229, Hart,R.G.,et al, 1999
Risk Assessment and Anticoagulation for Primary Stroke Prevention in Atrial Fibrillation
Stroke 30:1218-1222, Kalra,L.,et al, 1999
Signs and Symptoms of Duchenne Muscular Dystrophny and Becker Muscular Dystrophy Among Carriers in the Netherlands: A Cohort Study
Lancet 353:2116-2119, Hoogerwaard,E.M.,et al, 1999
What is Carpal Tunnell Syndrome?
JAMA 282:186-187,153, Franzblau,A.&Werner,R.A., 1999
A Patient Decision Aid Regarding Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation, A Randomized Controlled Trial
JAMA 282:737-743,779, Man-Son-Hing,M.,et al, 1999
Effect of Aldose Reductase Inhibition on Nerve Conduction and Morphomedtry in Diabetic Neuropathy
Neurol 53:580-591, Greene,D.A.,et al, 1999
Adult-Onset "Infant" Botulism:An Unusual Cause of Weakness in the Intensive Care Unit
Neurol 53:891, Li,L.Y.J.,et al, 1999
When Should Heparin be Given to Patients with Atrial Fibrillation-Related Embolic Brain Infarcts?
Arch Neurol 56:1059-1060, Caplan,L.R., 1999
Heparin in Acute Stroke with Atrial Fibrillation, Clinical Relevance of Very Early Treatment
Arch Neurol 56:1098-1102,1059, Chamorro,A.,et al, 1999
Acute Dystonia Induced by Drug Treatment
BMJ 319:623-626, vanHarten,P.N.,et al, 1999
Migraine in Pregnancy
Neurol 53:S26-S28, Aube,M., 1999
Primary Prevention of Arterial Thromboembolism in Non-Rheumatic Atrial Fibrillation in Primary Care:Randomised Controlled Trial Comparing Two Intensities of Coumarin with Aspirin
BMJ 319:958-964, Hellemons,B.S.P.,et al, 1999